alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b)

OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

In connection with the Annual Report of Rentrak Corporation (the Company) on Form 10-K for the fiscal year ended March 31, 2010, as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, William P. Livek, Director and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of
the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.



|    |  |                                                         
|--- |  | --------------------------------------------------------
|By: |  | /s/ William P. Livek                                    
|    |  | William P. Livek                                        
|    |  | Director and Chief Executive Officer
Rentrak Corporation

June 14,
2010
FIRST DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

No. 1D2023-2672

_____________________________

LONNIE GREEN,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

_____________________________

On appeal from the Circuit Court for Bay County.

Dustin Stephenson, Judge.

March 19, 2024

PER CURIAM.

DISMISSED.

RAY, KELSEY, and WINOKUR, JJ., concur.

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________

Lonnie Green, pro se, Appellant.
2

Ashley Moody, Attorney General, Tallahassee, for Appellee.
STATE EX REL. Rodney WASHINGTON v. STATE of Louisiana

No. 2017-KH-0547

Supreme Court of Louisiana.

May 25, 2018

**ON SUPERVISORY WRITS TO THE FIRST JUDICIAL DISTRICT COURT, PARISH OF CADDO**

PER CURIAM:

Denied. Relator does not identify an illegal term in his sentence, and therefore, his filing is properly construed as an application for post-conviction relief. *See* *State v. Parker* , 98-0256 (La. 5/8/98), 711 So.2d 694. As such, it is subject to the time limitation set forth in La.C.Cr.P. art. 930.8. Relator's application was not timely filed in the district court, and he fails to carry his burden to show that an exception applies. La.C.Cr.P. art. 930.8 ; *State ex rel. Glover v. State* , 93-2330 (La. 9/5/95), 660 So.2d 1189. The application is also repetitive. La.C.Cr.P. art. 930.4.

Relator has now fully litigated his application for post-conviction relief in state court. Similar to federal habeas relief, *see* 28 U.S.C. § 2244, Louisiana post-conviction procedure envisions the filing of a successive application only under the narrow circumstances provided in La.C.Cr.P. art. 930.4 and within the limitations period as set out in La.C.Cr.P. art. 930.8. Notably, the Legislature in 2013 La. Acts 251 *562amended that article to make the procedural bars against successive filings mandatory. Relator's claims have now been fully litigated in accord with La.C.Cr.P. art. 930.6, and this denial is final. Hereafter, unless he can show that one of the narrow exceptions authorizing the filing of a successive application applies, relator has exhausted his right to state collateral review. The district court is ordered to record a minute entry consistent with this per curiam.

CRICHTON, J., recused.
Billy Eugene BROWNING v. STATE

CR-15-1329

Court of Criminal Appeals of Alabama.

March 17, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
# U.S. Navy Issues Vaccine Guidance to Combat COVID-19

The Navy issued COVID-19 Vaccine guidance to combat the coronavirus pandemic with NAVADMIN 327/20 Dec. 16.This guidance amplifies Department of Defense (DOD) guidance for COVID-19 vaccination to service members, civilians and dependents within the Navy.

The COVID-19 vaccine distribution will be a phased, standardized, and coordinated plan for administering COVID-19 vaccines to protect our people, maintain readiness, and help return to normalcy. All Navy personnel are strongly encouraged to take the vaccine to protect their health, their families, their community, and lower the public health risks associated with the COVID-19 pandemic.

The vaccine is voluntary while under Federal Drug Administration (FDA) Emergency Use Authorization (EUA) approval.

“The nation and the Department of Defense are beginning to administer vaccines for the SARS-CoV-2 virus” said Chief of Naval Operations (CNO) Adm. Mike Gilday, “These vaccines, which are currently voluntary, are a proven effective measure to better protect you, our Navy and our Nation from this insidious threat.”

 

The COVID-19 vaccine is a pandemic vaccine and the distribution and administration follows protocols established by prior influenza vaccination seasons. Military Treatment Facilities (MTFs) will coordinate the administration of the vaccine with all supported Navy units to ensure operational readiness is maintained and the vaccine is administered when available. 

Navy Component Commanders (NCC) will determine vaccination plans for operational units.  Initial intent is to vaccinate units deploying within the next three to six months, subject to vaccine availability.

All COVID-19 mitigations measures such as facemasks, social distancing, and restriction of movement (ROM) sequester will remain in place until a sufficient percentage of the Navy population is immunized and the rate of infection reduced to no longer pose an operational risk to the force.

Side effects of the vaccine are expected to be mild, but may be similar to symptoms associated with COVID-19 infection.  If you have received a partial or full sequence of the vaccine and develop symptoms consistent with COVID-19 outside of expected side effects you should be tested for COVID-19 and follow current return to work guidance.

 

DOD Announces COVID-19 Vaccine Distribution Plan: https://www.defense.gov/Newsroom/Releases/Release/Article/2440556/dod-announces-covid-19-vaccine-distribution-plan/

 

Statement From HHS and DOD on FDA Emergency Use Authorization of a COVID-19 Vaccine Candidate: https://www.defense.gov/Newsroom/Releases/Release/Article/2445116/statement-from-hhs-and-dod-on-fda-emergency-use-authorization-of-a-covid-19-vac/
cc: Hon. Jerome Polaha, District Judge 

Jonathan Lawrence Meiring 

Reno City Attorney 

Washoe District Court Clerk 

SUPREME COURT 

OF 

NEVADA 2 

(0) [947A e
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 4634)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         NIGMS Initial Review Group Training and Workforce Development Study Section—D Review of Bridges to the Baccalaureate Applications.                    

*Date:*                         March 3, 2022.                    

*Time:*                         10:30 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Video Meeting).                    

*Contact Person:*                         Tracy Koretsky, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Room 3AN.12F, Bethesda, MD 20892, (301) 594-2886,                         *tracy.koretsky@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS)

Dated: January 24, 2022.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-01742 Filed 1-27-22; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Protocol
Systems, Inc. Condensed Consolidated Balance Sheet as of March 31, 1998 and
Condensed Consolidated Statement of Operations for the three months ended March
31, 1998 and is qualified in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                           8,935
<SECURITIES>                                    15,164
<RECEIVABLES>                                   14,014<F1>
<ALLOWANCES>                                       346
<INVENTORY>                                     12,106
<CURRENT-ASSETS>                                45,754
<PP&E>                                          14,880
<DEPRECIATION>                                  10,179
<TOTAL-ASSETS>                                  59,679
<CURRENT-LIABILITIES>                            7,010
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            86
<OTHER-SE>                                      52,080
<TOTAL-LIABILITY-AND-EQUITY>                    59,679
<SALES>                                         14,920
<TOTAL-REVENUES>                                14,920
<CGS>                                            8,007
<TOTAL-COSTS>                                    8,007
<OTHER-EXPENSES>                                 6,594
<LOSS-PROVISION>                                     0<F2>
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    319
<INCOME-TAX>                                        89
<INCOME-CONTINUING>                                230
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       230
<EPS-PRIMARY>                                     0.03
<EPS-DILUTED>                                     0.03
<FN>
<F1>Net of allowance
<F2>The amount of loss provision is not significant and has been included in other
expenses
</FN>
        

</TABLE>
Marie M. LOUIS, Appellant(s)/Petitioner(s), v. FEDERAL NATIONAL MORTGAGE ASSOCIATION, Appellee(s)/Respondent(s),

CASE NO.: 3D17-0544

District Court of Appeal of Florida, Third District.

OCTOBER 24, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Rocky Blake NASH, Appellant, v. STATE of Florida, Appellee.

No. 1D17-5275

District Court of Appeal of Florida, First District.

April 11, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Harman International Industries, Incorporated:

We consent to the
incorporation by reference in Registration Statement Nos. 33-28973, 33-60236, 33-59605, 333-02197,

333-28793, 333-32673, 333-103487, 333-103488 and
333-155962 on Form S-8, and 333-159985 and 333-154714 on Form S-3 of Harman International Industries, Incorporated of our report dated August 19, 2009, with respect to the consolidated balance sheets of Harman International Industries,
Incorporated and subsidiaries as of June 30, 2009 and 2008, and the related consolidated statements of operations, cash flows, and shareholders equity and comprehensive income, and the related financial statement schedule, for each of the years in
the three-year period ended June 30, 2009, and the effectiveness of internal control over financial reporting as of June 30, 2009, which report appears in the June 30, 2009 annual report on Form 10-K of Harman International Industries,
Incorporated.

As discussed in Note 10 to the consolidated financial statements, the Company adopted FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxesan interpretation of FASB Statement No. 109, effective July 1, 2007.





|             |  | 
|------------ |  | 
|            
|            
|/s/ KPMG LLP
|             |  | 

Stamford, CT

August
19, 2009
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 7
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<DEBT-HELD-FOR-SALE>                                 0
<DEBT-CARRYING-VALUE>                          2696220
<DEBT-MARKET-VALUE>                            2650210
<EQUITIES>                                       57239
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                 2753459
<CASH>                                         7076659
<RECOVER-REINSURE>                                   0
<DEFERRED-ACQUISITION>                          790137
<TOTAL-ASSETS>                                17610250
<POLICY-LOSSES>                                4351500
<UNEARNED-PREMIUMS>                            1397380
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                2865000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         26275
<OTHER-SE>                                     6871305
<TOTAL-LIABILITY-AND-EQUITY>                  17610250
<PREMIUMS>                                    11580130
<INVESTMENT-INCOME>                             440539
<INVESTMENT-GAINS>                               (208)
<OTHER-INCOME>                                 299,324
<BENEFITS>                                     7644155
<UNDERWRITING-AMORTIZATION>                     332633
<UNDERWRITING-OTHER>                           5992363
<INCOME-PRETAX>                              (1649525)
<INCOME-TAX>                                  (473662)
<INCOME-CONTINUING>                          (1175863)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (1175863)
<EPS-PRIMARY>                                   (0.45)
<EPS-DILUTED>                                   (0.45)
<RESERVE-OPEN>                                 4526316
<PROVISION-CURRENT>                            7503823
<PROVISION-PRIOR>                               140332
<PAYMENTS-CURRENT>                           (5328073)
<PAYMENTS-PRIOR>                             (2403490)
<RESERVE-CLOSE>                                4351500
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
EXHIBIT 23.1

Consent of Independent Auditors

Weconsent to the incorporation by reference in the Registration Statements (Forms S-3, Nos. 333-58296 and 333-65776) and related prospectuses of Insight Communications Company, Inc. for the registration of up to $1 billion in aggregate offering pricein various combinations of its Class A Common Stock, preferred stock, debt securities, warrants or subscription rights and the Registration Statement (Form S-8, No. 333-57808) pertaining to the Insight Communications Company, Inc. 1999 Stock OptionPlan of our reports dated February 25, 2003 with respect to the consolidated financial statements of Insight Communications Company, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2002.

/s/ ERNST & YOUNG LLP

New York, New York March 10, 2003
! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 !! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 "! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 #! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 $! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 %! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 &! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 '! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 (! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 )! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 !! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 "! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 #! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 $! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 %! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 &! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 '! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 (! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! )! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 !! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! !! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! "! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! #! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! $! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! %! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! &! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! '! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 ! (! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " )! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 "! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " !! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " "! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " #! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " $! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " %! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " &! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " '! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 " (! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # )! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 #! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # !! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # "! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # #! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # $! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # %! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # &! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # '! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 # (! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 $ )! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 $

2 3 * 4 . / 3 2 3 (

5 ( ' (

6 7 3 / '! " # $ & ' ( ) * + , - * ( . * / + 0 1

, # 1 1 $ !

8 3 9 : ; < 3 =

> ? @ & = A = > @ B C D A = & D E A @ F @ A A G B = > ? A G D G > > = A C C H I > G D C D H

> ? J 1 K J G A L M @ & I = > = > M
> @ B C D ? E G N E M M C E G L ? > G G O H C M @ C P

P = M @ > F C D = N G
#### IN RE: Victor Orlando RIVERA, Debtor, *782Victor Orlando Rivera, Appellant, v. Nancy K. Curry, Appellee.

No. 14-60070

United States Court of Appeals, Ninth Circuit.

Submitted January 18, 2017 *

Filed January 26, 2017

Victor Orlando Rivera, Pro Se

Nancy K. Curry, Chapter 13 Trustee, Los Angeles, CA, for Appellee

Before: TROTT, TASHIMA, and CALLAHAN, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R. App. P. 34(a)(2).

MEMORANDUM **

Victor Orlando Rivera appeals pro se from the Bankruptcy Appellate Panel’s (“BAP”) judgment dismissing his appeal from a bankruptcy court order dismissing his bankruptcy case. We have jurisdiction under 28 U.S.C. § 158(d). We independently review the bankruptcy court’s decision without deference to the BAP. *Turtle Rock Meadows Homeowners Ass’n v. Slyman (In re Skyman),*234 F.3d 1081, 1085 (9th Cir. 2000). We affirm in part and dismiss in part.

Rivera contends the bankruptcy court erred in dismissing his Chapter 13 bankruptcy petition because Rivera had converted his petition to Chapter 7 prior to the bankruptcy court entering its dismissal order. Like the BAP, we do not consider this argument in the first instance. *See Kaass Law v. Wells Fargo Bank,*N.A., 799 F.3d 1290, 1293 (9th Cir. 2015) (“Ordinarily, an appellate court will not hear an issue raised for the first time on appeal.”); *Consorzio Del Prosciutto Di Parma v. Domain Name Clearing Co., LLC,*346 F.3d 1193, 1195 (9th Cir. 2003) (“An appeal to this court cannot be used as a substitute [for seeking relief under Rule 60(b) ]” (citation and internal quotation marks omitted)).

Because the record reflects that Rivera failed to appeal timely from the bankruptcy court’s orders denying his motions to review his notice to convert his petition to one under chapter 7, we lack jurisdiction as to those orders. *See Bank of the West v. Wiersma (In re Wiersma),*483 F.3d 933, 938 (9th Cir. 2007) (“[T]he failure to timely file a notice of appeal is a jurisdictional defect barring appellate review.” (citation and internal quotation marks omitted)).

AFFIRMED in part, DISMISSED in part.

**

 This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
Exhibit 32.1

CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this
Quarterly Report on Form 10-Q of Virtus Investment Partners, Inc. (the Company) for the period ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the
undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.

Dated: November 3, 2010



|                                               
|-----------------------------------------------
|/s/    GEORGE R.
AYLWARD                       
|George R. Aylward                              
|President, Chief Executive Officer and Director
|                                               
|/s/    MICHAEL A.
ANGERTHAL                    
|Michael A. Angerthal                           
|Chief Financial Officer